ESPR

Esperion Therapeutics, Inc. is a biopharmaceutical company based in Ann Arbor, Michigan, dedicated to developing innovative therapies for patients with elevated low-density lipoprotein cholesterol (LDL-C). The company's primary focus is on transforming the treatment landscape for cardiovascular disease through its novel lipid-lowering agents. With a robust pipeline and a commitment to patient-centered solutions, Esperion is well-positioned to significantly impact the management of dyslipidemia and improve patient outcomes in a critical area of cardiovascular health.